Peptide Regulating Target Selectively

PPI-R-SP™:Protein-Protein Interaction Regulating Short Peptide

High Specificity and Pathologically Specific Regulation of Target

Minimizing Toxicity and Side Effects by Short Half-life in Blood

Peptide Regulating TGF-b Selectively

P2K: Proven Selective TGF-β Modulation in US Phase 3

E1K: Proven Selective TGF-β Modulation in Korea Phase 2

C1K: Proven Selective TGF-β Modulation in Korea Phase 1

ESAIDD™ AI-Driven Drug Discovery System

Accelerating the discovery of high-probability drug candidates

Powered by LLMs and Machine Learning Demonstrating ESAIDD’s Reliability through the Discovery of D1K, a Trop-2–Targeting Peptide

New Drugs for Unmet Needs

P2K – A Novel Therapy for Degenerative Disc Disease (DDD)

E1K – A Novel Therapy for Knee Osteoarthritis (OA)

M1K – A Novel Therapy for Alzheimer’s Disease (AD)